IPP Bureau
ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role
By IPP Bureau - April 13, 2026
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Unichem’s US arm recalls Buspirone tablets after stability test OOS result
By IPP Bureau - April 13, 2026
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
Ankura Hospitals strengthens pediatric center of excellence as complex child cases rise
By IPP Bureau - April 13, 2026
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
SRMIST to host global physiotherapy and hand rehabilitation conclave on 16-18 April
By IPP Bureau - April 13, 2026
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
Apollo Hospitals sets world record in robotic heart surgery with 100 procedures in 155 days
By IPP Bureau - April 12, 2026
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality
By IPP Bureau - April 12, 2026
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
GE HealthCare and Medtronic launch real-time brain surgery imaging integration
By IPP Bureau - April 12, 2026
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
Novartis expands global push to close life-saving gaps in heart disease & cancer care by 2030
By IPP Bureau - April 12, 2026
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
EMA gives green light to warmer & simpler delivery rules for Wegovy injection
By IPP Bureau - April 12, 2026
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Touchlight and SVF partner to advance next-gen Hepatitis B/D vaccine development
By IPP Bureau - April 12, 2026
The company says the platform offers improved manufacturability and functional advantages
Haemonetics gains FDA nod to expand VASCADE MVP XL for larger sheaths in heart procedures
By IPP Bureau - April 12, 2026
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
Revvity launches Signals BioDesign to transform molecular cloning
By IPP Bureau - April 12, 2026
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
Eli Lilly launches once-daily weight-loss pill Foundayo
By IPP Bureau - April 12, 2026
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Orbicular, Apotex win tentative USFDA nod for generic Ozempic
By IPP Bureau - April 11, 2026
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
ISDE India Edition 2026 spotlights minimally invasive therapies for esophageal cancer
By IPP Bureau - April 11, 2026
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
